Company Update (NYSE:PFE): Pfizer to pay $35 mln to U.S. states to settle Rapamune claims

[Reuters] – Pfizer Inc agreed to pay $35 million to 41 U.S. states and Washington, D.C. to settle claims that its Wyeth unit illegally marketed the drug Rapamune, and encouraged doctors and hospitals . . . → Read More: Company Update (NYSE:PFE): Pfizer to pay $35 mln to U.S. states to settle Rapamune claims Similar Articles: Market Update (NYSE:PFE): Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines Market Update: Pfizer Inc (NYSE:PFE) – Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine Market Update (NYSE:PFE): Pfizer prepares sweeter bid for AstraZeneca – report